83-12-5
Chemical Structure
Phenindione
Synonym(s): Rectadione
- CAS No.: 83-12-5
- Formula:C15H10O2
- Molecular Weight:222.24
IUPAC Name: 2-phenyl-1H-indene-1,3(2H)-dione
InChIKey: NFBAXHOPROOJAW-UHFFFAOYSA-N
SMILES: O=C1C(C2=CC=CC=C2)C(C3=C1C=CC=C3)=O
Biological Activity: Phenindione is an anticoagulant and can act as a vitamin K antagonist.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Phenindione | 98.21% | Phenindione is an anticoagulant and can act as a vitamin K antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Phenindione (Standard) | ≥98% | Phenindione (Standard) is the analytical standard of Phenindione. This product is intended for research and analytical applications. 0 | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Phenindione-d5 | 99.50% | Phenindione-d5 is deuterium labeled Phenindione, which is an anticoagulant which functions as a Vitamin K antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fluindione | Fluindione is a inhibitor of 5-lipoxygenase with the IC50 of 15 μM. Fluindione has antiinflammatory activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
SU-9055 | SU-9055 is an active compound. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Anti-infective agent 1 | Anti-infective agent 1 (compound 3a) is a potent and selective antiprotozoal and antimycobacterial agent. Anti-infective agent 1 shows antiparasitic activity against P. falciparum and T. brucei rhodesiense, with IC50 values of 10.95 and 0.06 μM, respectively. Anti-infective agent 1 shows antimycobacterial activity against Mycobacterium smegmatis with a MIC of 8 μg/mL. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bromindione | 98.25% | Bromindione is a potent and long-acting, Inandione-derived, oral anticoagulant compound. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Chlorindione (Standard) | ≥98% | Chlorindione (Standard) is the analytical standard of Chlorindione. This product is intended for research and analytical applications. Chlorindione (Chlophenadione) is a potent anticoagulant. Chlorindione also is a vitamin K1 antagonist. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Anisindione (Standard) | ≥98% | Anisindione (Standard) is the analytical standard of Anisindione. This product is intended for research and analytical applications. Anisindione is an oral indandione anticoagulant. Anisindione inhibits the formation of active procoagulant factors II, VII, IX and X. Anisindione can be used in anticoagulation-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Anthraquinone (Standard) | ≥98% | Anthraquinone (Standard) is the analytical standard of Anthraquinone. This product is intended for research and analytical applications. Anthraquinone is used as a precursor for dye formation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
9,10-Phenanthrenequinone | 99.72% | 9,10-Phenanthrenequinone is an inhibitor of claudin-5/CLDN5 that induces apoptosis via a NO synthase/ROS-dependent mechanism. 9,10-Phenanthrenequinone also promotes endothelial barrier dysfunction by promoting caspase activation and DNA fragmentation, and reducing CLDN5 expression and proteasomal proteolysis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fluindarol | Fluindarol is a phenylindandione derivative and an orally active anticoagulant. Fluindarol acts as a toxicant that induces organ and tissue haemorrhages and liver parenchymal necrosis in rats. Fluindarol exhibits acute and cumulative preclinical toxicity in rats, rabbits, and dogs, with higher toxicity in female rats than male rats. Fluindarol lacks analgesic action, produces only minor blood pressure effects, and does not alter circulation, respiration, CNS, or cardiac activity. Fluindarol is considered too toxic for clinical use based on preclinical data. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||